Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3 043 | [email protected] | www.racuraoncology.com 1 ASX Announcement Date of AGM and Closing Date for Director Nominations 5 October 2026 Racura Oncology Limited (“Racura” or the...
Date of AGM & Closing Date for Director Nominations
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Racura Oncology Ltd has announced the date for its Annual General Meeting and the closing date for director nominations. The AGM is scheduled for a specific time and location in Sydney. Nominations for director positions must be submitted in writing by a specified deadline. This announcement is made in accordance with ASX Listing Rule requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Racura Oncology
- Appendix 3Y - Dr Daniel Tillett
- RC220 MYC-silencing data to be presented FCS 26 conference
- Racura Oncology Adelaide Investor Briefing
- Notification regarding unquoted securities - RAC
- CPACS Trial Opens for RC220 Patient Enrolment in Korea
Later from Racura Oncology
- Racura Presents CPACS Data at GCOS 2026
- HARNESS-1 First Cohort Cleared
- Sept 2026 Quarterly Activities Report and Appendix 4C
- Letter to Shareholders, Notice of AGM & Proxy Form
- Racura Presents Bisantrene MYC Data at FCS 2026
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology